UB Paderborn / Katalog / Suche / in CDI

Oxaliplatin : Pharmacokinetics and chronopharmacological aspects

Clinical pharmacokinetics, 2000, Vol.38 (1), p.1-21

2000

Volltextzugriff (PDF)

Der Hofmeister und die Gouvernante: Ein Lustspiel in 5 Aufzügen

2019

Volltextzugriff (PDF)

Treatment of cancer cells with methioninase produces DNA hypomethylation and increases DNA synthesis

Cancer research (Chicago, Ill.), 2002-08, Vol.62 (16), p.4685-4689

2002

Volltextzugriff (PDF)

Persistent T lymphocyte rhythms despite suppressed circadian clock outputs in rats

American journal of physiology. Regulatory, integrative and comparative physiology, 1997-12, Vol.273 (6), p.1891-R1899

1997

Volltextzugriff (PDF)

Relationship of atypical melatonin rhythm with two circadian clock outputs in B6D2F1 mice

American journal of physiology. Regulatory, integrative and comparative physiology, 2000-04, Vol.278 (4), p.924

2000

Volltextzugriff (PDF)

Pharmacologic Modulation of Reduced Glutathione Circadian Rhythms with Buthionine Sulfoximine: Relationship with Cisplatin Toxicity in Mice

Toxicology and applied pharmacology, 1997-04, Vol.143 (2), p.281-290

1997

Volltextzugriff (PDF)

Relationship of atypical melatonin rhythm with two circadian clock outputs in B6D2F1 mice

American journal of physiology. Regulatory, integrative and comparative physiology, 2000-04, Vol.47 (4), p.R924-R930

2000

Volltextzugriff (PDF)

Persistent T lymphocyte rhythms despite suppressed circadian clock outputs in rats

American journal of physiology. Regulatory, integrative and comparative physiology, 1997-12, Vol.42 (6), p.R1891-R1899

1997

Volltextzugriff (PDF)

A chronopharmacologic phase II clinical trial with 5‐fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

Cancer, 1992-02, Vol.69 (4), p.893-900

1992

Volltextzugriff (PDF)

Fluorouracil Combined With the Pure (6S)-Stereoisomer of Folinic Acid in High Doses for Treatment of Patients With Advanced Colorectal Carcinoma: A Phase I–II Study

JNCI : Journal of the National Cancer Institute, 1992-03, Vol.84 (5), p.321-327

1992

Volltextzugriff (PDF)

Light-induced suppression of the rat circadian system

American journal of physiology. Regulatory, integrative and comparative physiology, 1995-05, Vol.37 (5), p.R1111-R1116

1995

Volltextzugriff (PDF)

Enhanced activity of mouse peritoneal cells after aclacinomycin administration

Cancer research (Chicago, Ill.), 1987-07, Vol.47 (13), p.3477-3484

1987

Volltextzugriff (PDF)

Cytotoxic synergism of methioninase in combination with 5-fluorouracil and folinic acid

Biochemical pharmacology, 2001-04, Vol.61 (7), p.867-876

2001

Volltextzugriff (PDF)

Analyse physique et experimentale du fonctionnement des chambres a etincelles a echantillonnage : etude de circuits a haute performance pur la sortie des informations et le declenchement

Metzger, Gerard

1969

Volltextzugriff (PDF)

Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: Relationship with mucosal toxicity in patients with cancer

Clinical pharmacology and therapeutics, 1994-08, Vol.56 (2), p.190-201

1994

Volltextzugriff (PDF)

Pharmacologic restoration of suppressed temperature rhythms in rats by melatonin, melatonin receptor agonist, S20242, or 8-OH-DPAT

European journal of pharmacology, 1998-04, Vol.347 (1), p.57-66

1998

Volltextzugriff (PDF)

Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer

The Lancet (British edition), 1997-11, Vol.350 (9087), p.1326-1326

1997

Volltextzugriff (PDF)

Conformation of 2-[(deoxyguanosin-8-ylacetyl)amino]fluorene differs in protein-free DNA and chromatin

Biochemistry (Easton), 1982-03, Vol.21 (6), p.1369-1374

1982

Volltextzugriff (PDF)

Relationship of atypical melatonin rhythm with two circadian clock outputs in B6D2F 1 mice

American journal of physiology. Regulatory, integrative and comparative physiology, 2000-04, Vol.278 (4), p.R924-R930

2000

Volltextzugriff (PDF)

Evidence for N-acetoxy-N-2-acetylaminofluorene induced covalent-like binding of some nonhistone proteins to DNA in chromatin

Biochemistry (Easton), 1979-02, Vol.18 (4), p.655-659

1979

Volltextzugriff (PDF)

5-Fluorouracil combined with the pure [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study of two consecutive regimens

Advances in experimental medicine and biology, 1993, Vol.339, p.81

1993

Volltextzugriff (PDF)

Circadian changes in mitoxantrone toxicity in mice: Relationship with plasma pharmacokinetics

International journal of cancer, 1994-11, Vol.59 (4), p.543-547

1994

Volltextzugriff (PDF)

Modulation of nonprotein sulphydryl compounds rhythm with buthionine sulphoximine : relationship with oxaliplatin toxicity in mice

Archives of toxicology, 1998-09, Vol.72 (9), p.574-579

1998

Volltextzugriff (PDF)

Structural models of the transmembrane domain of opioid receptors and proposed ligand binding modes for selective and non-selective opioid alkaloids

Metzger, Thomas Gerard

1996

Volltextzugriff (PDF)

In vitro binding of N-acetoxy-N-2-acetylaminofluorene to DNA in chromatin

Cancer research (Chicago, Ill.), 1975-10, Vol.35 (10), p.2738

1975

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Oxaliplatin : Pharmacokinetics and chronopharmacological aspects

Der Hofmeister und die Gouvernante: Ein Lustspiel in 5 Aufzügen

Treatment of cancer cells with methioninase produces DNA hypomethylation and increases DNA synthesis

Persistent T lymphocyte rhythms despite suppressed circadian clock outputs in rats

Relationship of atypical melatonin rhythm with two circadian clock outputs in B6D2F1 mice

Pharmacologic Modulation of Reduced Glutathione Circadian Rhythms with Buthionine Sulfoximine: Relationship with Cisplatin Toxicity in Mice

Relationship of atypical melatonin rhythm with two circadian clock outputs in B6D2F1 mice

Persistent T lymphocyte rhythms despite suppressed circadian clock outputs in rats

A chronopharmacologic phase II clinical trial with 5‐fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

Fluorouracil Combined With the Pure (6S)-Stereoisomer of Folinic Acid in High Doses for Treatment of Patients With Advanced Colorectal Carcinoma: A Phase I–II Study

Light-induced suppression of the rat circadian system

Enhanced activity of mouse peritoneal cells after aclacinomycin administration

Cytotoxic synergism of methioninase in combination with 5-fluorouracil and folinic acid

Analyse physique et experimentale du fonctionnement des chambres a etincelles a echantillonnage : etude de circuits a haute performance pur la sortie des informations et le declenchement

Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: Relationship with mucosal toxicity in patients with cancer

Pharmacologic restoration of suppressed temperature rhythms in rats by melatonin, melatonin receptor agonist, S20242, or 8-OH-DPAT

Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer

Conformation of 2-[(deoxyguanosin-8-ylacetyl)amino]fluorene differs in protein-free DNA and chromatin

Relationship of atypical melatonin rhythm with two circadian clock outputs in B6D2F 1 mice

Evidence for N-acetoxy-N-2-acetylaminofluorene induced covalent-like binding of some nonhistone proteins to DNA in chromatin

5-Fluorouracil combined with the pure [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study of two consecutive regimens

Circadian changes in mitoxantrone toxicity in mice: Relationship with plasma pharmacokinetics

Modulation of nonprotein sulphydryl compounds rhythm with buthionine sulphoximine : relationship with oxaliplatin toxicity in mice

Structural models of the transmembrane domain of opioid receptors and proposed ligand binding modes for selective and non-selective opioid alkaloids

In vitro binding of N-acetoxy-N-2-acetylaminofluorene to DNA in chromatin

Suchergebnisse filtern